Sarepta Therapeutics, Inc. (SRPT)
18.96
+0.12
(+0.61%)
USD |
NASDAQ |
Feb 25, 16:00
17.75
-1.20
(-6.36%)
After-Hours: 16:17
Sarepta Therapeutics Total Assets (Quarterly) : 3.493B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.604B |
| Merck & Co., Inc. | -- |
| Pfizer Inc. | -- |
| REGENXBIO, Inc. | 525.20M |
| Keros Therapeutics, Inc. | 742.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.173B |
| Shareholders Equity (Quarterly) | 1.320B |
| Debt to Equity Ratio | 0.947 |
| Current Ratio | 2.950 |
| Net Debt Paydown Yield | 1.19% |